Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alternate Health Club vs Breeze Meds

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.3

Alternate Health Club

Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform
★★★3.7

Starting at $129/mo

CompoundedSemaglutideTirzepatideLegitScript Verified
Visit Alternate Health Club
7.3

Breeze Meds

Best for compounded GLP-1 access with named prescribers and 4-pharmacy network
★★★3.7

Starting at $199/mo

CompoundedSemaglutideTirzepatideAll 50 States
Visit Breeze Meds

Side-by-Side Comparison

FeatureAlternate Health ClubBreeze Meds
Overall Score7.3/107.3/10
Starting Price$129/mo$199/mo
Editorial Rating3.7 ★ /53.7 ★ /5
Features6 features6 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alternate Health Club

Pros

  • $129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
  • $169/month compounded tirzepatide is competitive with established compounded-tirz platforms
  • Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
  • LegitScript Verified seal displayed in the footer
  • U.S.-licensed clinicians explicitly mentioned

Cons

  • Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
  • State of incorporation NOT disclosed
  • Per-state availability NOT enumerated — verify your state ships before committing
  • Pharmacy partners NOT publicly named — material YMYL transparency gap
  • Lab work NOT clearly disclosed as included
  • Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
  • First-month discount or trial offer NOT disclosed

Breeze Meds

Pros

  • Available in all 50 US states
  • LegitScript certified seal displayed in footer
  • Publicly named medical team with NPI numbers: Dr. Ana Lisa Carr MD (NPI 1689841744) and Dr. Kelly Tenbrink MD (NPI 1346482684)
  • Four named 503A pharmacy partners: Belmar Pharma Solutions, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx
  • Both injectable and oral formats available for semaglutide and tirzepatide
  • No FDA warning letters or litigation on record as of 2026-04-09

Cons

  • Runs on the same Lion MD clinician network and the same 4 compounding pharmacies as Care Bare Rx and Synergy Rx — if you're comparing the three brands, be aware you're comparing three storefronts on top of one underlying operation, not three independent providers
  • Compounded medications are not FDA-approved
  • Compounded vs. brand-name drug sourcing is ambiguously disclosed on the product pages
  • Terms of Service page returns a 404 (Privacy Policy is present) — a procedural transparency gap
  • Insurance acceptance is not clearly disclosed beyond FSA/HSA eligibility

Our Verdict

Both Alternate Health Club and Breeze Meds score equally well overall — the right choice depends on your priorities. Choose Alternate Health Club if you want patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform, or Breeze Meds if compounded GLP-1 access with named prescribers and 4-pharmacy network matters most to you.

Glossary references

Key terms in this article, linked to their canonical definitions.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.